Stem Cell Transplants
Treatments for polymyositis and dermatomyositis include biological agents, exercise, immunosuppressants, steroids, IVIg, and stem cell transplants. (Also see Autoimmune Diseases, and Dermatomyositis/Polymyositis)
The Use of Rituximab in the Management of Refractory Dermatomyositis. This is a retrospective study of 25 patients with dermatomyositis who were treated with rituximab. PubMed, J Drugs Dermatol. 2017 Feb 1;16(2):162-166.
Dermatomyositis and Polymyositis Associated with Malignancy: A 21-year Retrospective Study. In patients with tumor-associated myositis, it was more frequently necessary to administer other immunosuppressive drugs along with glucocorticoids. J Rheumatol ;35:438-44.
Physical exercise as a treatment for adult and juvenile myositis. These data suggest that intensive aerobic exercise and resistance training could reduce disease activity and inflammation and improve muscle metabolism. PubMed, J Intern Med, 2016 Jul;280(1):75-96.
How is Polymyositis Treated? Initially, polymyositis is treated with high doses of corticosteroids. MedicineNet.com.
The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis (DM/PM): a systematic review. Current evidence appears to support the use of tacrolimus in refractory PM/DM and PM/DM-ILD patients and it seems to be a safe drug that improves both muscle strength and lung function, and is well tolerated by patients. PubMed, Clin Rheumatol, 09/02/2015.
Case Report: Intravenous Immune Globulin in Amyopathic Dermatomyositis (ADM) – Report of Two Cases and Review of the Literature. We present both cases in describing IVIG as a rescue and maintenance steroid–sparing agent in the treatment of severe refractory ADM. PubMed, Open Rheumatol J.
Successful Treatment With Intravenous High-Dose Immunoglobulin For Cardiomyopathy In Dermatomyositis Complicated With Rapid Progressive Interstitial Pneumonia And Macrophage Activation Syndrome. This is the first report that IVIg may be effective for cardiomyopathy in dermatomyositis. ATS Journal.
Stem cell transplantation in myositis. The aim of this clinical trial from 2005-2015 is to test whether it is safe to transplant stem cells from the blood into patients with myositis whose condition has not responded to conventional treatments. Muscular Dystrophy Campaign.
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Pam Hop, Margaret Roof, Winifred Schillberg, Arnold Slotkin, and Juliet Youkhana. Plus donations in honor of Kim Thwaits, and in loving memory of Marta Marx, Jim Miller, and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE sclero.org button.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: